tiprankstipranks
Trending News
More News >
Lifeway Foods (LWAY)
:LWAY
Advertisement

Lifeway Foods (LWAY) AI Stock Analysis

Compare
181 Followers

Top Page

LWAY

Lifeway Foods

(NASDAQ:LWAY)

Select Model
Select Model
Select Model
Neutral 58 (OpenAI - 4o)
Rating:58Neutral
Price Target:
$25.00
▼(-7.89% Downside)
Lifeway Foods' overall stock score is primarily influenced by its strong financial performance, particularly in revenue growth and balance sheet strength. However, significant weaknesses in cash flow management and bearish technical indicators weigh heavily on the score. The high P/E ratio suggests potential overvaluation, further impacting the stock's attractiveness.
Positive Factors
Revenue Growth
Strong revenue growth indicates robust demand for Lifeway's products, enhancing its market position and supporting long-term expansion.
Balance Sheet Strength
Minimal leverage reduces financial risk, providing Lifeway with flexibility to invest in growth opportunities and withstand economic downturns.
Product Innovation
Continuous innovation in product offerings attracts new customers and retains existing ones, driving sustainable revenue growth and market differentiation.
Negative Factors
Cash Flow Management
Challenges in converting income into cash can limit Lifeway's ability to reinvest in the business, impacting long-term financial stability.
Net Profit Margin Decline
Declining net profit margins suggest rising costs or inefficiencies, which may erode profitability if not addressed, affecting long-term viability.
Leadership Change
Leadership changes can disrupt strategic direction and execution, potentially impacting Lifeway's ability to maintain its competitive edge.

Lifeway Foods (LWAY) vs. SPDR S&P 500 ETF (SPY)

Lifeway Foods Business Overview & Revenue Model

Company DescriptionLifeway Foods, Inc. is a leading manufacturer and marketer of probiotic dairy products, primarily known for its kefir, a fermented milk drink rich in beneficial probiotics. Founded in 1986 and headquartered in Morton Grove, Illinois, the company operates in the health and wellness sector, focusing on the production of cultured dairy products that promote digestive health. Lifeway's core offerings include a variety of kefir products, yogurt, and other probiotic-rich foods, targeting health-conscious consumers seeking functional dairy alternatives.
How the Company Makes MoneyLifeway Foods generates revenue primarily through the sale of its probiotic dairy products, with kefir being the flagship item in its product lineup. The company distributes its products through various channels, including grocery stores, health food retailers, and online platforms, which enables it to reach a broad consumer base. Key revenue streams include direct retail sales as well as partnerships with major grocery chains and distributors, which help expand the brand's market presence. Additionally, Lifeway Foods engages in collaborations with health and wellness influencers and participates in trade shows to enhance brand visibility and drive sales. The company's focus on innovation and product development, such as introducing new flavors and dairy alternatives, also contributes to revenue growth by attracting new customers and retaining existing ones.

Lifeway Foods Earnings Call Summary

Earnings Call Date:Aug 12, 2025
(Q1-2025)
|
% Change Since: |
Next Earnings Date:Nov 17, 2025
Earnings Call Sentiment Positive
The earnings call was generally positive, highlighting sustained growth and strategic expansions in product offerings and distribution. Despite some inflationary pressures and strategic reductions in retail relationships, the company has continued to see significant financial and operational success, with record-breaking sales and increased net income.
Q1-2025 Updates
Positive Updates
Sustained Net Sales Growth
Net sales increased by $1.5 million or 3.3% compared to the first quarter in 2024, driven by higher volumes of Lifeway branded products despite strategic elimination of certain retail relationships.
Record-High Weekly Sales
Achieved a Lifeway record high week of sales at the end of April, surpassing $5 million in gross sales, a 35% increase from the same week in the prior year.
Consistent Growth in Lifeway Farmers' Cheese
First quarter saw significant growth in the Lifeway Farmers' Cheese category, with expanded distribution into 1,400 Albertsons stores and commitments from nearly 1,000 additional stores.
Increased Net Income and EPS
Net income increased to $3.5 million, with EPS of $0.23 per share, compared to $2.4 million and $0.17 per share in the first quarter of 2024.
Strategic Investments Yielding Returns
Strategic investments in sales and marketing continue to drive growth, with effective ROI from promotions and expansions like the New Year campaign and influencer partnerships.
Innovative Product Offerings
Introduced new products such as lactose-free organic Kefir flavor fusions and Probiotic Smoothies with Collagen, which have been well received by consumers.
Distribution Expansion
Expanded distribution in key channels, including CVS, Target, Publix, and Walmart, and increased presence in 40 airports through WHSmith.
Negative Updates
Inflationary Cost Pressures
Gross profit margin at 24% affected by inflationary pricing in milk, Lifeway's largest raw material, and costs related to promotions and distribution expansion.
Elimination of Retail Relationship
Strategic decision to eliminate a retail relationship that contributed to quarterly net sales, though intended to prioritize branded offerings.
Company Guidance
In the first quarter of 2025, Lifeway Foods demonstrated strong financial performance, achieving net sales of $46.1 million, marking a 3.3% increase compared to the same period in 2024. The company's gross profit margin stood at 24%, supported by heightened volumes of Lifeway branded products despite facing inflationary pressures in milk costs. Lifeway reported a net income of $3.5 million, with an EPS of $0.23 per basic and diluted common share, up from $2.4 million or $0.17 per basic share in the prior year. The growth was driven by strategic investments in marketing and distribution, including expanded placements in major retailers like CVS, Target, and Walmart, as well as a significant distribution of Farmers' Cheese into 1,400 Albertsons stores. The company also highlighted its commitment to further brand awareness through various marketing campaigns and e-commerce strategies, while reiterating its expectation to achieve $45 million to $50 million in adjusted EBITDA by fiscal year 2027. Additionally, Lifeway achieved a record high week of sales in April, surpassing $5 million in gross sales, propelled by demand for its Kefir and Farmers' Cheese products.

Lifeway Foods Financial Statement Overview

Summary
Lifeway Foods shows strong revenue growth and a robust balance sheet with minimal debt. However, cash flow management is a concern, with zero free cash flow in 2024 and challenges in converting income into cash.
Income Statement
85
Very Positive
Lifeway Foods has demonstrated strong revenue growth, increasing from $93.66 million in 2019 to $186.82 million in 2024. The company has maintained a healthy gross profit margin, reaching 26% in 2024, indicating efficient cost management. However, the net profit margin has seen some fluctuations, dropping to 4.8% in 2024 from 7.1% in 2023, which suggests potential challenges in controlling non-operating expenses. The EBIT and EBITDA margins also reflect strong operational performance, with 7.4% each in 2024.
Balance Sheet
90
Very Positive
Lifeway Foods maintains a robust balance sheet, evidenced by a low debt-to-equity ratio of 0.001 in 2024, indicating minimal leverage and financial risk. The equity ratio stands at 79.4%, demonstrating significant equity financing. Return on equity has remained solid at 12.5% in 2024, although it has declined from 18.8% in 2023, suggesting some pressure on profitability relative to shareholders' equity.
Cash Flow
60
Neutral
Lifeway Foods' cash flow performance shows areas for improvement. The operating cash flow to net income ratio was 0 in 2024, down from 1.49 in 2023, indicating challenges in converting income into cash. Free cash flow was also zero in 2024, impacted by capital expenditures and investing activities. The company needs to focus on enhancing cash generation and managing capital expenditures effectively.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue193.02M186.82M160.12M141.57M119.06M102.03M
Gross Profit50.20M48.57M42.44M26.79M28.71M26.93M
EBITDA19.68M17.46M20.20M5.08M8.61M8.19M
Net Income10.61M9.03M11.37M924.00K3.31M3.23M
Balance Sheet
Total Assets98.27M90.55M81.65M69.00M70.87M60.07M
Cash, Cash Equivalents and Short-Term Investments21.22M16.73M13.20M4.44M9.23M7.93M
Total Debt220.00K117.00K2.92M6.68M7.46M3.11M
Total Liabilities19.57M18.64M21.22M21.43M21.74M13.21M
Stockholders Equity78.70M71.91M60.44M47.57M49.13M46.85M
Cash Flow
Free Cash Flow1.32M6.26M12.59M538.00K3.64M4.49M
Operating Cash Flow8.63M12.96M16.94M3.99M5.56M6.38M
Investing Cash Flow-1.98M-6.68M-4.41M-4.03M-7.14M-1.89M
Financing Cash Flow-65.00K-2.75M-3.78M-4.75M2.88M-405.00K

Lifeway Foods Technical Analysis

Technical Analysis Sentiment
Negative
Last Price27.14
Price Trends
50DMA
28.28
Negative
100DMA
27.23
Negative
200DMA
25.06
Negative
Market Momentum
MACD
-0.89
Positive
RSI
28.69
Positive
STOCH
12.02
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For LWAY, the sentiment is Negative. The current price of 27.14 is above the 20-day moving average (MA) of 26.24, below the 50-day MA of 28.28, and above the 200-day MA of 25.06, indicating a bearish trend. The MACD of -0.89 indicates Positive momentum. The RSI at 28.69 is Positive, neither overbought nor oversold. The STOCH value of 12.02 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for LWAY.

Lifeway Foods Risk Analysis

Lifeway Foods disclosed 20 risk factors in its most recent earnings report. Lifeway Foods reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Lifeway Foods Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
$428.88M92.5717.44%19.34%-12.64%
$237.73M18.079.15%4.33%-6.33%
$20.33B14.63-3.31%3.23%1.93%-12.26%
$386.45M23.763.20%5.88%-68.62%
$365.34M34.7114.46%9.19%-23.91%
$347.52M-9.76-89.88%-4.59%-19.09%
$417.66M-27.07%13.05%-72.80%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
LWAY
Lifeway Foods
23.99
-0.76
-3.07%
NATR
Nature's Sunshine Products
13.48
0.49
3.77%
USNA
USANA Health
21.15
-16.76
-44.21%
MAMA
Mama's Creations
10.59
3.48
48.95%
BRCC
BRC
1.27
-1.89
-59.81%
WEST
Westrock Coffee
4.41
-2.48
-35.99%

Lifeway Foods Corporate Events

Business Operations and Strategy
Lifeway Foods Extends Shareholder Rights Agreement
Neutral
Oct 30, 2025

On October 29, 2025, Lifeway Foods, Inc. announced an extension of its Shareholder Rights Agreement by one year, now expiring on October 29, 2026. The decision was made to protect against potential acquisition of control by shareholders without paying a premium, given the company’s concentrated share ownership and the potential for a substantial number of shares to become available for sale. This move aims to ensure that all shareholders can realize the full value of their investment and safeguard against control tactics without fair compensation.

The most recent analyst rating on (LWAY) stock is a Hold with a $25.00 price target. To see the full list of analyst forecasts on Lifeway Foods stock, see the LWAY Stock Forecast page.

Shareholder Meetings
Lifeway Foods Schedules 2025 Annual Shareholder Meeting
Neutral
Oct 9, 2025

Lifeway Foods, Inc. announced that its 2025 annual meeting of shareholders is scheduled for December 16, 2025. Shareholder proposals or nominations must be submitted by October 20, 2025, adhering to the company’s by-laws and Rule 14a-8 requirements.

The most recent analyst rating on (LWAY) stock is a Buy with a $33.00 price target. To see the full list of analyst forecasts on Lifeway Foods stock, see the LWAY Stock Forecast page.

Executive/Board Changes
Jody Levy Resigns as Director of Lifeway Foods
Neutral
Oct 1, 2025

On October 1, 2025, Jody Levy resigned from her position as a director at Lifeway Foods, Inc., a company known for its production of probiotic and functional foods. Her resignation was not due to any disagreements with the company’s operations, policies, or practices.

The most recent analyst rating on (LWAY) stock is a Buy with a $33.00 price target. To see the full list of analyst forecasts on Lifeway Foods stock, see the LWAY Stock Forecast page.

Business Operations and StrategyExecutive/Board ChangesLegal Proceedings
Lifeway Foods Announces Cooperation Agreement with Danone
Positive
Oct 1, 2025

On September 30, 2025, Lifeway Foods, Inc. announced a Cooperation Agreement with Danone North America PBC, which includes a stay of litigation related to a Stockholders’ Agreement and plans for a board refreshment. The agreement outlines governance changes, including the appointment of independent directors and the separation of the Chair and CEO roles. Danone has agreed to support the board’s director candidates at upcoming annual meetings and to waive certain rights under the Stockholders’ Agreement. This strategic move aims to enhance corporate governance and maximize shareholder value while maintaining stability and focus on Lifeway’s core mission.

The most recent analyst rating on (LWAY) stock is a Hold with a $29.00 price target. To see the full list of analyst forecasts on Lifeway Foods stock, see the LWAY Stock Forecast page.

Business Operations and StrategyFinancial DisclosuresM&A Transactions
Danone Withdraws Acquisition Proposal for Lifeway Foods
Neutral
Sep 18, 2025

On September 18, 2025, Lifeway Foods announced that Danone has withdrawn its proposal to acquire the company. Lifeway remains focused on executing its strategic plan to enhance shareholder value, having formed a Strategic Review Committee to oversee opportunities. The company reported record-breaking sales in Q1 and Q2 2025, with continued growth into Q3, highlighting its strong market position and consistent performance.

The most recent analyst rating on (LWAY) stock is a Buy with a $33.00 price target. To see the full list of analyst forecasts on Lifeway Foods stock, see the LWAY Stock Forecast page.

Financial Disclosures
Lifeway Foods Reports 20% Sales Increase in Q3
Positive
Sep 2, 2025

On September 2, 2025, Lifeway Foods announced estimated unaudited net sales of $39.1 million for the first two months of the third quarter, marking a 20% increase from the previous year. This growth highlights the company’s strong market position and increasing consumer demand for its kefir and high-protein cheese products, reinforcing its leadership in the probiotic nutrition sector.

The most recent analyst rating on (LWAY) stock is a Buy with a $33.00 price target. To see the full list of analyst forecasts on Lifeway Foods stock, see the LWAY Stock Forecast page.

Lifeway Foods Reports Record Sales and Growth
Aug 13, 2025

Lifeway Foods, Inc. is a leading U.S. supplier of kefir and fermented probiotic foods, recognized for its innovative products in the dairy industry.

Business Operations and StrategyFinancial Disclosures
Lifeway Foods Reports Strong Q3 Start with 20% Growth
Positive
Aug 12, 2025

Lifeway Foods reported record financial results for the second quarter of 2025, with net sales reaching $53.9 million, marking an 18% increase on a comparable basis. The company also announced a strong start to the third quarter with estimated net sales of $26.4 million through August 11, 2025, reflecting a 20% year-over-year growth. This performance underscores Lifeway’s leadership in the kefir category and its ability to capitalize on consumer trends towards wellness and probiotic foods. The company was recognized as Processor of the Year by Dairy Foods magazine, highlighting its innovation and impact in the dairy industry.

The most recent analyst rating on (LWAY) stock is a Buy with a $28.00 price target. To see the full list of analyst forecasts on Lifeway Foods stock, see the LWAY Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 30, 2025